Genes of murine cytomegalovirus exist as a number of distinct genotypes

Virology

Volumn 352, Issue 2, 2006, Pages 450-465

  Smith, Lee M ^a   Shellam, Geoffrey R ^a   Redwood, Alec J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Gene polymorphism; Immune evasion; Multiple genotypes; Murine cytomegalovirus; Wild mice

Indexed keywords

ANIMAL CELL; ARTICLE; ASSAY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA POLYMORPHISM; EMBRYO; GENE SEQUENCE; GENETIC CONSERVATION; GENETIC VARIABILITY; GENOTYPE; HETERODUPLEX ANALYSIS; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; MEDICAL RESEARCH; MOUSE; MURINE CYTOMEGALOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS GENE; VIRUS ISOLATION; VIRUS STRAIN;

ANIMALS; ANIMALS, LABORATORY; ANIMALS, WILD; BASE SEQUENCE; CELLS, CULTURED; CYTOMEGALOVIRUS; DNA, VIRAL; EVOLUTION, MOLECULAR; GENES, VIRAL; GENOTYPE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUROMEGALOVIRUS; PHYLOGENY; SEQUENCE HOMOLOGY, NUCLEIC ACID; SPECIES SPECIFICITY; VARIATION (GENETICS);

HUMAN HERPESVIRUS 5; MAIZE CHLOROTIC MOTTLE VIRUS; MURID HERPESVIRUS 1;

EID: 33747268006     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.04.031     Document Type: Article

References (55)

1. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., and Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296 (2002) 1323-1326
2. Arav-Boger R., Willoughby R.E., Pass R.F., Zong J.C., Jang W.J., Alcendor D., and Hayward G.S. Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease. J. Infect. Dis. 186 (2002) 1057-1064
3. Arav-Boger R., Foster C.B., Zong J., and Pass R. Human cytomegalovirus-encoded a-chemokines exhibit high sequence variability in congenitally infected newborns. J. Infect. Dis. 193 (2006) 788-791
4. Booth T.W., Scalzo A.A., Carrello C., Lyons P.A., Farrell H.E., Singleton G.R., and Shellam G.R. Molecular and biological characterization of new strains of murine cytomegalovirus isolated from wild mice. Arch. Virol. 132 (1993) 209-220
5. Brocchieri L., Kledal T.N., Karlin S., and Mocarski E.S. Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice. J. Virol. 79 (2005) 7570-7596
6. Bubeck A., Reusch U., Wagner M., Ruppert T., Muranyi W., Kloetzel P.M., and Koszinowski U.H. The glycoprotein gp48 of murine cytomegalovirus - proteasome-dependent cytosolic dislocation and degradation. J. Biol. Chem. 277 (2002) 2216-2224
7. Campanella J.J., Bitincka L., and Smalley J. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences. BMC Bioinformatics 4 (2003) 29
8. Cha T., Tom E., Kemble G.W., Duke G.M., Mocarski E.S., and Spaete R.R. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70 (1996) 78-83
9. Chapman T.L., and Bjorkman P.J. Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog. J. Virol. 72 (1998) 460-466
10. Chee M.S., Bankier A.T., Beck S., Bohni R., Brown C.M., Cerny R., Horsnell T., Hutchison III C.A., Kouzardies T., Martignetti J.A., Preddie E., Satchwell S.C., Tomlinson P., Weston K.M., and Barrell B.G. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Topics Microbiol. Immunol. 154 (1990) 125-169
11. Creevey C.J., and McInerney J.O. CRANN: detecting adaptive evolution in protein-coding DNA sequences. Bioinformatics 19 (2003) 1726
12. Cretney E., Degli-Esposti M.A., Densley E.H., Farrell H.E., Davis-Poynter N.J., and Smyth M.J. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J. Exp. Med. 190 (1999) 435-444
13. Crnkovic-Mertens I., Messerle M., Milotic I., Szepan U., Kucic N., Krmpotic A., Jonjic S., and Koszinowski U.H. Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. J. Virol. 72 (1998) 1377-1382
14. Davis-Poynter N.J., Lynch D.M., Vally H., Shellam G.R., Rawlinson W.D., Barrell B.G., and Farrell H.E. Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus. J. Virol. 71 (1997) 1521-1529
15. Diefenbach A., Jamieson A.M., Liu S.D., Shastri N., and Raulet D.H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1 (2000) 119-126
16. Dolan A., Cunningham C., Hector R.D., Hassan-Walker A.F., Lee L., Addison C., Dargan D.J., McGeoch D.J., Gatherer D., Emery V.C., Griffiths P.D., Sinzger C., McSharry B.P., Wilkinson G.W.G., and Davison A.D. Genetic content of wild-type human cytomegalovirus. J. Gen. Virol. 85 (2004) 1301-1312
17. Dunn W., Chou C., Li H., Hai R., Patterson D., Stolc V., Zhu H., and Liu F. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U.S.A. 100 24 (2003) 14223-14228
18. Farrell H.E., Vally H., Lynch D.M., Fleming P., Shellam G.R., Scalzo A.A., and Davis-Poynter N.J. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo.[comment]. Nature 386 6624 (1997) 510-514
19. Fleming P., Davis-Poynter N., Degli-Esposti M., Densley E., Papadimitriou J., Shellam G., and Farrell H. The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity. J. Virol. 73 8 (1999) 6800-6809
20. Gorman S., Harvey N., Moro D., Lloyd M.L., Smith L.M., Lawson M., and Shellam G.R. Mixed infection with multiple strains of murine cytomegalovirus occurs following simultaneous or sequential infection of immunocompetent mice. J. Gen. Virol. 87 (2006) 1123-1132
21. Haberland M., Meyer-Konig U., and Hufert F.T. Variation within the glycoprotein B gene of human cytomegalovirus is due to homologous recombination. J. Gen. Virol. 80 (1999) 1495-1500
22. Hudson J.B., Walker D.G., and Altamirano M. Analysis in vitro of two biologically distinct strains of murine cytomegalovirus. Arch. Virol. 102 (1988) 289-295
23. Kavanagh D.G., Gold M.C., Wagner M., Koszinowski U.H., and Hill A.B. The multiple immune-evasion genes of murine cytomegalovirus are not redundant. M4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. J. Exp. Med. 194 (2001) 967-978
24. Kavanagh D.G., Koszinowski U.H., and Hill A.B. The murine cytomegalovirus immune evasion protein m4/gp34 forms biochemically distinct complexes with class I MHC at the cell surface and in a pre-Golgi compartment. J. Immunol. 167 (2001) 3894-3902
25. Kleijnen M.F., Huppa J.B., Lucin P., Mukherjee S., Farrell H., Campbell A.E., Koszinowski U.H., Hill A.B., and Ploegh H.L. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J. 16 (1997) 685-694
26. Krmpotic A., Hasan M., Loewendorf A., Saulig T., Halenius A., Lenac T., Polic B., Bubic I., Kriegeskorte A., Pernjak-Pugel E., Messerle M., Hengel H., Busch D.H., Koszinowski U.H., and Jonjic S. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J. Exp. Med. 201 (2005) 211-220
27. Kubota A., Kubota S., Farrell H.E., Davis-Poynter N., and Takei F. Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144. Cell. Immunol. 191 (1999) 145-151
28. Kuroiwa Y., Nagai K., Okita L., and Tsutsumi H. Genetic variability and molecular epidemiology of respiratory syncytial virus subgroup a strains in Japan determined by heteroduplex mobility assay. J. Clin. Microbiol. 42 (2004) 2048-2053
29. Lodoen M., Ogasawara K., Hamerman J.A., Arase H., Houchins J.P., Mocarski E.S., and Lanier L.L. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 197 (2003) 1245-1253
30. Lodoen M.B., Abenes G., Umamoto S., Houchins J.P., Liu F., and Lanier L.L. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. J. Exp. Med. 200 (2004) 1075-1081
31. Loewendorf A., Kruger C., Borst E.M., Wagner M., Just U., and Messerle M. Identification of a mouse cytomegalovirus gene selectively targeting CD86 expression on antigen-presenting cells. J. Virol. 78 (2004) 13062-13071
32. Loh L.C., Locke D., Melnychuk R., and Laferte S. The RGD sequence in the cytomegalovirus DNA polymerase accessory protein can mediate cell adhesion. Virology 272 (2000) 302-314
33. Lyons P.A., Allan J.E., Carrello C., Shellam G.R., and Scalzo A.A. Effect of natural sequence variation at the H-2Ld-restricted CD8+ T cell epitope of the murine cytomegalovirus ie1-encoded pp89 on T cell recognition. J. Gen. Virol. 77 (1996) 2615-2623
34. Malarkannan S., Shih P.P., Eden P.A., Horng T., Zuberi A.R., Christianson G., Roopenian D., and Shastri N. The molecular and functional characterization of a dominant minor H antigen, H60. J. Immunol. 161 (1998) 3501-3509
35. Martin D.P., Williamson C., and Posada D. RDP2: recombination detection and analysis from sequence alignments. Bioinformatics 21 (2005) 260-262
36. Melnychuk R.M., Smith P., Kreklywich C.N., Ruchti F., Vomaske J., Hall L., Loh L., Nelson J.A., Orloff S.L., and Streblow D.N. Mouse cytomegalovirus M33 is necessary and sufficient in virus-induced vascular smooth muscle cell migration. J. Virol. 79 (2005) 10788-10795
37. Murphy E., Yu D., Grimwood J., Schmutz J., Dickson M., Jarvis M., Hahn G., Nelson J., Myers R., and Shenk T. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 14976-14981
38. Natarajan K., Hicks A., Mans J., Robinson H., Guan R., Mariuzza R., and Margulies D. Crystal structure of the murine cytomegalovirus MHC-I homologue m144. J. Mol. Biol. 358 1 (2006) 157-171
39. Osborn J.E. Cytomegalovirus and Other Herpesviruses. In: Foster H.L., Small J.D., and Fox J.G. (Eds). The Mouse in Biomedical Research vol. II (1982) 267-292
40. Rawlinson W.D., Farrell H.E., and Barrell B.G. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70 (1996) 8833-8849
41. Reusch U., Muranyi W., Lucin P., Burgert H.G., Hengel H., and Koszinowski U.H. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J. 18 (1999) 1081-1091
42. Rossini G., Pignatelli S., Dal Monte P., Camozzi D., Lazzarotto T., Gabrielli L., Gatto M.R., and Landini M.P. Monitoring for human cytomegalovirus infection in solid organ transplant recipients through antigenemia and glycoprotein N (gN) variants: evidence of correlation and potential prognostic value of gN genotypes. Microbes Infect. 7 (2005) 890-896
43. Saederup N., and Mocarski Jr. E.S. Fatal attraction: cytomegalovirus-encoded chemokine homologs. Curr. Top. Microbiol. Immunol. 269 (2002) 235-256
44. Sawadogo S., Adje-Toure C., Bile C.E., Ekpini R.E., Chorba T., and Nkengasong J.N. Field evaluation of the gag-based heteroduplex mobility assay for genetic subtyping of circulating recombinant forms of human immunodeficiency virus type 1 in Abidjan, Cote d'Ivoire. J. Clin. Microbiol. 41 (2003) 3056-3059
45. Smith M.G. Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease. Proc. Soc. Exp. Biol. Med. 92 (1956) 424-430
46. Smith H.R., Heusel J.W., Mehta I.K., Kim S., Dorner B.G., Naidenko O.V., Iizuka K., Furukawa H., Beckman D.L., Pingel J.T., Scalzo A.A., Fremont D.H., and Yokoyama W.M. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 8826-8831
47. Stanton R., Westmoreland D., Fox J.D., Davison A.J., and Wilkinson G.W. Stability of human cytomegalovirus genotypes in persistently infected renal transplant recipients. J. Med. Virol. 75 (2005) 42-46
48. Steininger C., Schmied B., Sarcletti M., Geit M., and Puchhammer-Stockl E. Cytomegalovirus genotypes present in cerebrospinal fluid of HIV-infected patients. AIDS 19 (2005) 273-278
49. Sweet C. The pathogenicity of cytomegalovirus. FEMS Microbiol. Rev. 23 (1999) 457-482
50. Vales-Gomez M., Shiroishi M., Maenaka K., and Reyburn H.T. Genetic variability of the major histocompatibility Class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2. J. Virol. 79 (2005) 2251-2260
51. Voigt V., Forbes C.A., Tonkin J.N., Degli-Esposti M.A., Smith H.R., Yokoyama W.M., and Scalzo A.A. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 13483-13488
52. Waldhoer M., Kledal T.N., Farrell H., and Schwartz T.W. Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities. J. Virol. 76 (2002) 8161-8168
53. White P.A., Li Z., Zhai X., Marinos G., and Rawlinson W.D. Mixed viral infection identified using heteroduplex mobility analysis (HMA. Virology 271 (2000) 382-389
54. Xu J., Lyons P.A., Carter M.D., Booth T.W., Davis-Poynter N.J., Shellam G.R., and Scalzo A.A. Assessment of antigenicity and genetic variation of glycoprotein B of murine cytomegalovirus. J. Gen. Virol. 77 (1996) 49-59
55. Ziegler H., Thale R., Lucin P., Muranyi W., Flohr T., Hengel H., Farrell H., Rawlinson W., and Koszinowski U.H. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6 (1997) 57-66